PROTAGONIST THERAPEUTICS, INC. (PTGX) Files An 8-K Results of Operations and Financial Condition
Item2.02. Results of Operations and Financial Condition.
On November14, 2016, Protagonist Therapeutics, Inc. reported its
financial results for the three months ended September30, 2016. A
copy of the press release titled Protagonist Therapeutics Reports
Third Quarter 2016 Financial Results and Provides Corporate
Update, is furnished to Item2.02 as Exhibit 99.1 hereto.
Item9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit |
Description |
|
| 99.1 |
Press release, dated November 14, 2016, titled Protagonist Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update. |
The information in this report, including the exhibit hereto,
shall not be deemed to be filed for purposes of Section18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that Section11 and 12(a)(2) of the
Securities Act of 1933, as amended. The information contained
herein and in the accompanying exhibit shall not be incorporated
by reference into any filing with the U.S. Securities and
Exchange Commission made by Protagonist Therapeutics, Inc.,
whether made before or after the date hereof, regardless of any
general incorporation language in such filing.
About PROTAGONIST THERAPEUTICS, INC. (PTGX)
